Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04336020 · ClinicalTrials.gov registry record
The DETECT(Digital Engagement & Tracking for Early Control, & Treatment) Study
A clinical trial of Influenza and Virus, sponsored by Scripps Translational Science Institute.
- Recruiting
- Registry status
- 100,000
- Enrollment target
- 1
- Study location
NCT04336020: Recruiting study of Influenza and Virus, sponsored by Scripps Translational Science Institute.
NCT04336020 is a study of Influenza and Virus that is actively recruiting participants, run by Scripps Translational Science Institute. The registered enrollment target is 100,000 participants, above the 36,163-participant average among 156 other Influenza trials with a reported enrollment target (177% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04336020, a study of Influenza and Virus, is actively recruiting participants, sponsored by Scripps Translational Science Institute.
- RECRUITING
- Registry status
- 100,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Develop an app-based nationwide study of individuals who routinely use a smartwatch or other wearable activity tracker to determine if individualized tracking of changes in heart rate, activity and sleep can provide an early indication of influenza-like illnesses (ILI) and possibly other viral infections.
Study Locations (1)
California
- Scripps Research Translational Institute - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100,000 participants |
| Start Date | 2020-03-24 |
| Est. Completion | 2025-04 |
What NCT04336020 shows while recruiting
NCT04336020 is an observational study that tracks outcomes without assigning an intervention. Its 100,000 participants enrollment target places it among the larger protocols in the corpus, above the 36,163-participant average among 156 other Influenza trials with a reported enrollment target (177% higher).
The record links to 2 conditions, with Influenza appearing as the primary indexed condition, and to 0 interventions.
NCT04336020 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04336020 about?
NCT04336020 is a clinical study titled "The DETECT(Digital Engagement & Tracking for Early Control, & Treatment) Study". Develop an app-based nationwide study of individuals who routinely use a smartwatch or other wearable activity tracker to determine if individualized tracking of changes in heart rate, activity and sleep can provide an early indication of influenza-like illnesses (ILI) and possibly other viral infec...
What is the current status of trial NCT04336020?
This trial is currently recruiting. The enrollment target is 100,000 participants. The study started on 2020-03-24. Estimated completion is 2025-04.
What conditions does trial NCT04336020 study?
This clinical trial studies the following conditions: Influenza, Virus.
Who is sponsoring clinical trial NCT04336020?
This trial is sponsored by Scripps Translational Science Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04336020 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Influenza
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04336020's enrollment target sits among peer trials
100,000 5th of 156 higher than 151 of 156 other Influenza trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Influenza trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
pH1N1 Blinded Challenge Study
RECRUITING · Phase 1
-
B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older Adults
RECRUITING · Phase 4
-
High vs. Standard Dose Influenza Vaccines in Lung Transplant (Repeater)
RECRUITING · Phase 2
-
Influenza Immunization in Adults Over Age 75
RECRUITING · NA
-
H5N1 Milk Detection Study
RECRUITING · NA
-
Screening for LID Clinical Studies Unit Healthy Volunteer Protocols
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02620852 · 100,000 participants · NA
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
- NCT03277365 · 100,000 participants · NA
MyGeneRank: A Digital Platform for Next-Generation Genetic Studies
- NCT04281823 · 100,000 participants
DeBakey Cardiovascular Magnetic Resonance Study
- NCT04869111 · 100,000 participants · NA
The BrainHealth Project
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI